In vitro activity of clinically implemented β-lactams against Aerococcus urinae: presence of non-susceptible isolates in Switzerland

New Microbiol. 2014 Oct;37(4):563-6. Epub 2014 Oct 1.

Abstract

We analyzed the in vitro susceptibility to several ?-lactams and vancomycin of 80 Aerococcus urinae isolates collected during 2011-2012 in Switzerland. MICs were determined by Etest (bioMérieux) on Müller-Hinton agar with 5% sheep blood and interpreted according to the CLSI and EUCAST criteria set for viridans streptococci. MIC50/90 for penicillin, amoxicillin, ceftriaxone and vancomycin were 0.016/0.064 mg/l, 0.032/0.064 mg/l, 0.125/0.5 mg/l and 0.38/0.5 mg/l, respectively. Three (3.8%) isolates were resistant to ceftriaxone regardless of the criteria used (MICs ?2 mg/l); one of them was also non-susceptible to penicillin (MIC of 0.25 mg/l) according to CLSI. β-lactam resistance in A. urinae is a concern and suggests that more studies are needed to determine the molecular mechanisms of such resistance.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aerococcus / drug effects*
  • Aerococcus / genetics
  • Aerococcus / isolation & purification
  • Aged
  • Aged, 80 and over
  • Anti-Bacterial Agents / pharmacology*
  • Drug Resistance, Bacterial
  • Female
  • Gram-Positive Bacterial Infections / microbiology*
  • Humans
  • Male
  • Microbial Sensitivity Tests
  • Switzerland
  • beta-Lactams / pharmacology*

Substances

  • Anti-Bacterial Agents
  • beta-Lactams